| RS2136725569 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2136728245 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS2136728385 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS2136728464 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Joubert syndrome |
| RS2136748724 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2136751258 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2136753495 |
RPS26
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 10, Diamond-Blackfan anemia 10 |
| RS2136753773 |
RPS26
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia 10, Diamond-Blackfan anemia |
| RS2136753785 |
RPS26
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 10, Diamond-Blackfan anemia |
| RS2136753850 |
RPS26
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia 10, Diamond-Blackfan anemia |
| RS2136763097 |
FGD4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2136767620 |
MYL2
|
Health Risk |
Pathogenic |
Congenital heart disease, Congenital heart disease |
| RS2136770901 |
MYL2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2136774043 |
MYL2
|
Health Risk |
Likely pathogenic |
Primary familial hypertrophic cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS2136811371 |
AAAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS2136811976 |
AAAS
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS2136814350 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Joubert syndrome |
| RS2136815265 |
ERBB3
|
Health Risk |
Pathogenic |
Visceral neuropathy, familial |
| RS2136817458 |
CNTN1
|
Health Risk |
Pathogenic |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS2136818517 |
ERBB3
|
Health Risk |
Likely pathogenic |
Visceral neuropathy, familial |
| RS2136820957 |
AAAS
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS2136822199 |
ERBB3
|
Health Risk |
Likely pathogenic |
Visceral neuropathy, familial |
| RS2136822757 |
ERBB3
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2136823066 |
TNFRSF1A
|
Health Risk |
Likely pathogenic |
TNF receptor-associated periodic fever syndrome (TRAPS), TNF receptor-associated periodic fever syndrome (TRAPS) |
| RS2136827755 |
ALG9
|
Health Risk |
Pathogenic |
ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation |
| RS2136828141 |
LRP6
|
Health Risk |
Likely pathogenic |
— |
| RS2136838531 |
TCF7L2
|
Health Risk |
Pathogenic |
— |
| RS2136852410 |
ORAI1
|
Health Risk |
Pathogenic |
Myopathy, tubular aggregate |
| RS2136853046 |
ORAI1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to ORAI1 deficiency, Myopathy |
| RS2136865918 |
SCNN1A
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism, type IB1 |
| RS2136875298 |
LRP6
|
Health Risk |
Pathogenic |
— |
| RS2136876881 |
ALG8
|
Health Risk |
Pathogenic |
ALG8 congenital disorder of glycosylation, ALG8 congenital disorder of glycosylation |
| RS2136877292 |
GYS2
|
Health Risk |
Pathogenic |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disorder due to hepatic glycogen synthase deficiency |
| RS2136885834 |
LRP6
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2136887072 |
POLR3B
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism |
| RS2136894487 |
EHMT1
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2136899636 |
ALG8
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG8 congenital disorder of glycosylation, Polycystic liver disease 3 with or without kidney cysts |
| RS2136903056 |
ALG8
|
Health Risk |
Likely pathogenic |
Polycystic liver disease 3 with or without kidney cysts, Polycystic liver disease 3 with or without kidney cysts |
| RS2136906563 |
GYS2
|
Health Risk |
Likely pathogenic |
— |
| RS2136910908 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2136911405 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2136911634 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2136913413 |
GYS2
|
Health Risk |
Likely pathogenic |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disorder due to hepatic glycogen synthase deficiency |
| RS2136914556 |
LRP6
|
Health Risk |
Pathogenic |
— |
| RS2136915887 |
ALG8
|
Health Risk |
Pathogenic |
ALG8 congenital disorder of glycosylation, ALG8 congenital disorder of glycosylation |
| RS2136919555 |
CNTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS2136919683 |
LRP6
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2136929776 |
TCF7L2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2136932206 |
FGD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4H |
| RS2136936118 |
ALG9
|
Health Risk |
Pathogenic |
ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation |
| RS2136937347 |
POLR3B
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, demyelinating |
| RS2136937857 |
AMHR2
|
Health Risk |
Pathogenic |
— |
| RS2136938115 |
AMHR2
|
Health Risk |
Likely pathogenic |
Persistent Mullerian duct syndrome, Persistent Mullerian duct syndrome |
| RS2136938446 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136939497 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136940605 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2136943263 |
AMHR2
|
Health Risk |
Likely pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2136943353 |
KCNC2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 103, Developmental and epileptic encephalopathy 103 |
| RS2136943442 |
ATM
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Hereditary cancer-predisposing syndrome |
| RS2136943757 |
KCNC2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 103, Developmental and epileptic encephalopathy 103 |
| RS2136944093 |
KCNC2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2136944431 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2136944684 |
KCNC2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 103, Developmental and epileptic encephalopathy 103 |
| RS2136946265 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2136946469 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136948126 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136948975 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136949935 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136950036 |
ACADS
|
Health Risk |
Pathogenic |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS2136950565 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2136952289 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2136952659 |
CNTN1
|
Health Risk |
Pathogenic |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS2136953216 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136953867 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2136954627 |
PPP1R12A
|
Health Risk |
Likely pathogenic |
— |
| RS2136958216 |
CEP290
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2136959456 |
DNAH10
|
Health Risk |
Pathogenic |
Spermatogenic failure 56, Spermatogenic failure 56 |
| RS2136960831 |
CD27
|
Health Risk |
Pathogenic |
— |
| RS2136964385 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Joubert syndrome |
| RS2136964542 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2136964738 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2136966486 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2136997832 |
PPP1R12A
|
Health Risk |
Likely pathogenic |
Genitourinary and/or brain malformation syndrome, Genitourinary and/or brain malformation syndrome |
| RS2136998055 |
LRP6
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2136999020 |
POLR3B
|
Health Risk |
Conflicting classifications of pathogenicity |
POLR3B-related disorder, POLR3B-related disorder |
| RS2137001936 |
POLR3B
|
Health Risk |
Pathogenic |
— |
| RS2137001947 |
POLR3B
|
Health Risk |
Pathogenic |
— |
| RS2137002084 |
POLR3B
|
Health Risk |
Pathogenic |
— |
| RS2137005362 |
POLR3B
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism |
| RS2137006602 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, Ovarian serous cystadenocarcinoma |
| RS2137017154 |
POLR3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, demyelinating |
| RS2137023331 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2137025722 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2137026687 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2137027657 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2137028448 |
PPP1R12A
|
Health Risk |
Pathogenic |
Genitourinary and/or brain malformation syndrome, Genitourinary and/or brain malformation syndrome |
| RS2137028850 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2137030040 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2137030434 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2137030876 |
COX6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |